TrialRheumatology (Oxford, England)2023

Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.

Laura C Coates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.